Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Precision dosing of olanzapine in anorexia nervosa
NL-OMON53540Recruiting
- Sponsor
- Erasmus MC
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of olanzapine in anorexia nervosa (AN) (2 arms), sponsored by Erasmus MC. Primary endpoints: Pharmacokinetic parameters of olanzapine and Pharmacokinetic differences between AN and non-AN patients. Started Nov 2023; status: recruiting.
02
Drugs
olanzapine
03
Conditions
anorexia nervosa (AN)
Beyond the preview
Go deeper on NL-OMON53540.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON53540.